[Chemotherapy for prostate cancers].
Naito
Katsusuke
K
Department of Specific Organ Medicine, Yamaguchi University School of Medicine.
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000077143:Docetaxel; D004334:Drug Administration Schedule; D004961:Estramustine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage / Q000031:analogs & derivatives*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D043823:Taxoids; D014747:Vinblastine / Q000008:administration & dosage
D043823:Taxoids; D000077143:Docetaxel; D004961:Estramustine; D014747:Vinblastine; D005047:Etoposide; D017239:Paclitaxel